We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+4.26%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.06%
10 Year Est. Return
AUM
$24.5B
AUM Growth
+$1.31B
Cap. Flow
+$569M
Cap. Flow %
2.32%
Top 10 Hldgs %
15.71%
Holding
3,091
New
800
Increased
1,401
Reduced
859
Closed
15

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$23.2M
2
JNJ icon
Johnson & Johnson
JNJ
+$21M
3
MSFT icon
Microsoft
MSFT
+$20.5M
4
DOW icon
Dow Inc
DOW
+$20.2M
5
JPM icon
JPMorgan Chase
JPM
+$15.1M

Sector Composition

Rank Sector Weight
1 Technology 18.77%
2 Financials 17.2%
3 Healthcare 13.08%
4 Consumer Discretionary 10.3%
5 Communication Services 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MYE icon
2401
Myers Industries
MYE
$1.16B
$92K ﹤0.01%
+4,799
New +$86.4K
ACH
2402
Accendra Health
ACH
$80.7M
$92K ﹤0.01%
28,967
-66,109
-70% -$225K
MOR
2403
DELISTED
MorphoSys AG American Depositary Shares
MOR
$92K ﹤0.01%
+3,791
New +$94K
RAD
2404
DELISTED
Rite Aid Corporation
RAD
$92K ﹤0.01%
11,414
+5,063
+80% +$43.7K
AVLR
2405
DELISTED
Avalara, Inc.
AVLR
$92K ﹤0.01%
+1,269
New +$81.9K
MYOK
2406
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$92K ﹤0.01%
+1,835
New +$89.3K
AMC icon
2407
AMC Entertainment Holdings
AMC
$2.38B
$91K ﹤0.01%
981
-732
-43% -$97.5K
NXRT
2408
NexPoint Residential Trust
NXRT
$551M
$91K ﹤0.01%
+2,188
New +$85.5K
MLNX
2409
DELISTED
Mellanox Technologies, Ltd.
MLNX
$91K ﹤0.01%
+824
New +$94.9K
ELAN icon
2410
Elanco Animal Health
ELAN
$11.6B
$90K ﹤0.01%
+2,670
New +$86.7K
PDS
2411
Precision Drilling
PDS
$1.11B
$90K ﹤0.01%
2,393
+69
+3% +$3.03K
VRTV
2412
DELISTED
VERITIV CORPORATION
VRTV
$90K ﹤0.01%
4,636
-5,662
-55% -$131K
AMBA icon
2413
Ambarella
AMBA
$2.76B
$89K ﹤0.01%
+2,016
New +$90.3K
AIFU
2414
AIFU Inc
AIFU
$60M
$89K ﹤0.01%
+7
New +$79.7K
MGP
2415
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
$89K ﹤0.01%
+2,915
New +$92.4K
ADAP
2416
DELISTED
Adaptimmune Therapeutics
ADAP
$88K ﹤0.01%
+21,992
New +$89.7K
AMRX icon
2417
Amneal Pharmaceuticals
AMRX
$6.3B
$88K ﹤0.01%
12,333
-7,330
-37% -$74.9K
CYCN
2418
DELISTED
Cyclerion Therapeutics
CYCN
$88K ﹤0.01%
+383
New +$108K
EEX
2419
DELISTED
Emerald Holding
EEX
$88K ﹤0.01%
7,870
-4,838
-38% -$60.3K
NKSH icon
2420
National Bankshares
NKSH
$272M
$88K ﹤0.01%
+2,268
New +$90.5K
TVRD
2421
Tvardi Therapeutics
TVRD
$23.9M
$88K ﹤0.01%
+114
New +$80.1K
IVC
2422
DELISTED
Invacare Corporation
IVC
$88K ﹤0.01%
16,967
-2,559
-13% -$16.7K
ACIA
2423
DELISTED
Acacia Communications Inc
ACIA
$88K ﹤0.01%
+1,875
New +$98.6K
SSTK icon
2424
Shutterstock
SSTK
$180M
$87K ﹤0.01%
+2,210
New +$91.7K
CLDR
2425
DELISTED
Cloudera, Inc.
CLDR
$87K ﹤0.01%
16,503
+1,160
+8% +$10.7K

Similar funds

Aperio Group's Q2 2019 Portfolio in Review

As of Q2 2019, Aperio Group held 3,091 positions worth $24.5B, up 5.7% from $23.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Aperio Group's Q2 2019 filing shows 800 new, 1,401 increased, 859 reduced and 15 closed positions. Its largest new stake was Dow Inc: 383,303 shares worth $18.9M. The largest sale was American National Group, Inc. Common Stock, an estimated $36.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q2 2019 buy was Dow Inc: 383,303 shares worth $18.9M.
  • Aperio Group added most to AT&T in Q2 2019, an estimated $23.2M increase.
  • Aperio Group's biggest Q2 2019 reduction was American National Group, Inc. Common Stock, cutting an estimated $36.1M.
  • Aperio Group fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $6.06M.
  • Aperio Group's ten largest holdings make up 16% of its $24.5B portfolio in Q2 2019.
  • Aperio Group opened 800 new positions and closed 15 in Q2 2019.
  • Aperio Group's portfolio value rose 5.7% quarter-over-quarter to $24.5B.

Based on Aperio Group's 13F filing for Q2 2019, filed 30 Jul 2019.